These 7 laggard stocks of CY22 are on the rise in CY23, do you own any?
1/8
Stronger than you think
Investing in stocks involves certain amounts of risk, and selecting the right stock can be a challenging task. Even when the market trend is generally weak, some stocks may defy the trend and increase in value, while others may experience the opposite outcome. For instance, in CY22, despite the benchmark index increasing by 4.5%, several stocks underwent a significant decline. However, in CY23, these stocks rebounded strongly.
ET Markets has examined stocks that experienced a decline of over 40% in the previous calendar year (CY22), but have now achieved more than double-digit returns in CY23. From the Nifty500 package, we have identified 7 stocks that meet these criteria (Data Source: ACE Equity). Trendlyne SWOT analysis suggests that these stocks have more strengths than weaknesses.
ETBFSI
2/8
Zensar Technologies
Price return in CY23 so far: 31%, while in CY22 it has fallen: 59% CMP: Rs 280 | 52-week high: Rs 359 ROA improving since last 2 year Growth in net profit with increasing profit margin (QoQ) Company with low debt Annual net profits improving for last 2 years Book value per share improving for last 2 years Company with zero promoter pledge FII / FPI or institutions increasing their shareholding
iStock
3/8
PB Fintech
Price return in CY23 so far: 30%, while in CY22 it has fallen: 53% CMP: Rs 583 | 52-week high: Rs 803 Growth in net profit with increasing profit margin (QoQ) Company with no debt Increasing profits every quarter for the past 4 quarters Increasing revenue every quarter for the past 2 quarters FII / FPI or institutions increasing their shareholding
ETMarkets.com
4/8
Aurobindo Pharma
Price return in CY23 so far: 29%, while in CY22 it has fallen: 40% CMP: Rs 566 | 52-week high: Rs 686 Growth in net profit with increasing profit margin (QoQ) Company with low debt Book value per share improving for last 2 years FII / FPI or institutions increasing their shareholding Stock gained more than 20% in one month
Agencies
5/8
One97 Communications
Price return in CY23 so far: 23%, while in CY22 it has fallen: 60% CMP: Rs 651 | 52-week high: Rs 844 RoCE improving in last 2 years Growth in net profit with increasing profit margin (QoQ) Company with no debt Increasing revenue every quarter for the past 4 quarters Increasing profits every quarter for the past 4 quarters
ETMarkets.com
6/8
Medplus Health Services
Price return in CY23 so far: 16%, while in CY22 it has fallen: 41% CMP: Rs 716 | 52-week high: Rs 1019 Company with low debt Increasing revenue every quarter for the past 4 quarters Increasing profits every quarter for the past 2 quarters Improving cash flow from operation for last 2 years Annual net profits improving for last 2 years FII / FPI or institutions increasing their shareholding
ETMarkets.com
7/8
Firstsource Solutions
Price return in CY23 so far: 11%, while in CY22 it has fallen: 44% CMP: Rs 114 | 52-week high: Rs 132 Company with low debt Increasing revenue every quarter for the past 2 quarters Increasing profits every quarter for the past 2 quarters Annual net profits improving for last 2 years Book value per share Improving for last 2 years Company with xero promoter pledge FII/FPI or institutions increasing their shareholding
iStock
8/8
Indian Energy Exchange
Price return in CY23 so far: 11%, while in CY22 it has fallen: 45% CMP: Rs 155 | 52-week high: Rs 237 Company with no debt Increasing profits every quarter for the past 2 quarters Improving cash flow from operation for last 2 years Improving net cash flow for last 2 years Annual net profits improving for last 2 years